Vasculitis

• 

  Subject Areas on Research

  • ANCA--the rheumatologist's perspective 1992. 
  • Acute frosted retinal periphlebitis. 
  • Acute host-mediated endothelial injury after adenoviral gene transfer in normal rabbit arteries: impact on transgene expression and endothelial function. 
  • American College of Rheumatology Criteria for the diagnosis of vasculitis. 
  • An association between fetal parvovirus B19 infection and fetal anomalies: a report of two cases. 
  • Angiographically defined primary angiitis of the CNS: is it really benign? 
  • Angiopoietin-2 confers Atheroprotection in apoE-/- mice by inhibiting LDL oxidation via nitric oxide. 
  • Angiotensin type 2 receptor is expressed in murine atherosclerotic lesions and modulates lesion evolution. 
  • Antiphospholipid antibodies: findings at arteriography. 
  • Are inflammatory factors related to retinal vessel caliber? The Beaver Dam Eye Study. 
  • Aseptic lymphocyte-dominated vasculitis-associated lesion: a clinicopathologic review of an underrecognized cause of prosthetic failure. 
  • Assessing the performance of the Birmingham Vasculitis Activity Score at diagnosis for children with antineutrophil cytoplasmic antibody-associated vasculitis in A Registry for Childhood Vasculitis (ARChiVe). 
  • Assessment of the item selection and weighting in the Birmingham vasculitis activity score for Wegener's granulomatosis. 
  • Atherosclerosis 2005: recent discoveries and novel hypotheses. 
  • Atrophie blanche. A disorder associated with defective release of tissue plasminogen activator. 
  • COVID-19: Thrombosis, thromboinflammation, and anticoagulation considerations. 
  • Changing concepts in pathophysiology of the vasculitides. 
  • Circulating immune complexes in dermatologic disease. 
  • Classification, presentation, and initial treatment of Wegener's granulomatosis in childhood. 
  • Cloned endothelium derived from autoimmune vascular disease retain structural and functional characteristics of normal endothelial cells. 
  • Cocaine-induced pseudovasculitis. 
  • Cogan syndrome: studies in thirteen patients, long-term follow-up, and a review of the literature. 
  • Cryptococcus-like changes in the setting of vasculitis. 
  • Cyclophosphamide therapy of severe systemic necrotizing vasculitis. 
  • Cytokine-induced mobilization of circulating endothelial progenitor cells enhances repair of injured arteries. 
  • Cytokines and adhesion molecules in the pathogenesis of vasculitis. 
  • Defective release of tissue plasminogen activator in systemic and cutaneous vasculitis. 
  • Deficiency of Adenosine Deaminase 2 in Adults and Children: Experience From India. 
  • Diagnosis and treatment of the systemic and cutaneous necrotizing vasculitis syndromes. 
  • Diagnosis of intracranial vasculitis: a multi-disciplinary approach. 
  • Diagnostic and therapeutic approach to the patient with vasculitis. 
  • Disseminated infection with rapidly growing mycobacteria. 
  • Early-onset stroke and vasculopathy associated with mutations in ADA2. 
  • Essential role for Smad3 in regulating MCP-1 expression and vascular inflammation. 
  • Histopathologic changes in anti-angiotensin II type 1 receptor antibody-positive kidney transplant recipients with acute rejection and no donor specific HLA antibodies. 
  • Identification of human T cell leukemia virus in a Japanese patient with adult T cell leukemia and cutaneous lymphomatous vasculitis. 
  • Infantile pulmonary hypertension associated with foreign body vasculitis. 
  • Inflammatory mechanisms. 
  • Kawasaki disease--a cause of vasculitis in children. 
  • Kidney lesions in Rocky Mountain spotted fever: a light-, immunofluorescence-, and electron-microscopic study. 
  • Kruppel-like factor 15 is critical for vascular inflammation. 
  • Large vessel vasculitis of the central nervous system in systemic lupus erythematosus: report and review of the literature. 
  • Limitations of the 1990 American College of Rheumatology classification criteria in the diagnosis of vasculitis. 
  • Liposarcoma presenting as an intraluminal ureteral mass. 
  • Livedo reticularis: a form of allergic vasculitis. Report of 3 cases. 
  • LncRNA-MAP3K4 regulates vascular inflammation through the p38 MAPK signaling pathway and cis-modulation of MAP3K4. 
  • Lymphocytic vasculitis involving the central nervous system occurs in patients with X-linked lymphoproliferative disease in the absence of Epstein-Barr virus infection. 
  • Managing contraception and pregnancy in the rheumatologic diseases. 
  • Meningitis, vasculitis, and cerebritis caused by CNS histoplasmosis: radiologic-pathologic correlation. 
  • Meta-analysis of genome-wide association studies in >80 000 subjects identifies multiple loci for C-reactive protein levels. 
  • Minidose heparin therapy for vasculitis of atrophie blanche. 
  • Miscellaneous vasculitic syndromes including Behçet's disease and central nervous system vasculitis. 
  • Mucocutaneous disease in pediatric human immunodeficiency virus infection. 
  • Multiple unusual manifestations of Wegener's granulomatosis: breast mass, microangiopathic hemolytic anemia, consumptive coagulopathy, and low erythrocyte sedimentation rate. 
  • Musculoskeletal syndromes associated with malignancy. 
  • Myocardial involvement in Rocky Mountain spotted fever. 
  • Non-atherosclerotic vascular disease in the young. 
  • Ocular manifestations and concepts of systemic vasculitides. 
  • Pathogenic mechanisms of vessel damage in vasculitis syndromes. 
  • Peripheral neuropathy and connective tissue disease. Watch for this twosome when hunting for a diagnosis. 
  • Plasma thrombospondin as an indicator of intravascular platelet activation in patients with vasculitis. 
  • Polypoidal choroidal vasculopathy and systemic lupus erythematosus. 
  • Pregnancy outcomes among patients with vasculitis. 
  • Rheumatologic manifestations of cancer. 
  • Rocky mountain spotted fever in childhood. 
  • Similar CD19 dysregulation in two autoantibody-associated autoimmune diseases suggests a shared mechanism of B-cell tolerance loss. 
  • Smooth Muscle Peroxisome Proliferator-Activated Receptor γ Plays a Critical Role in Formation and Rupture of Cerebral Aneurysms in Mice In Vivo. 
  • Sural neuropathy: etiologies and predisposing factors. 
  • Tetracycline toxicity presenting as generalized vasculitis. 
  • The coagulopathy, endotheliopathy, and vasculitis of COVID-19. 
  • The impact of cyclophosphamide on menstruation and pregnancy in women with rheumatologic disease. 
  • The spectrum of vasculitis: clinical, pathologic, immunologic and therapeutic considerations. 
  • The vulnerable endothelium: priming the vascular endothelium for thrombosis with unfractionated heparin: biologic plausibility for observations from the Superior Yield of the New Strategy of Enoxaparin, Revascularization and GlYcoprotein IIb/IIIa Inhibitors (SYNERGY) trial. 
  • Therapy for granulomatous angiitis. 
  • Topical conjunctival corticosteroid therapy for malignant atrophic papulosis (Kohlmeier-Degos disease). 
  • Transcranial doppler sonography to monitor cerebral vasculitis. 
  • Treatment of Mycobacterium haemophilum infection with an antibiotic regimen including clarithromycin. 
  • Use of immunosuppressive agents in the treatment of severe ocular and vascular manifestations of Cogan's syndrome. 
  • Utility of FDG PET/CT in inflammatory cardiovascular disease. 
  • Vasculitis and Pregnancy. 
  • Vasculitis as a Major Morbidity Factor in Patients With Partial RAG Deficiency. 
• 

  Keywords of People

  • Allen, Nancy Bates, Professor Emeritus of Medicine, Medicine, Rheumatology and Immunology
  • Bradford, William Dalton, Professor of Pathology, Pathology